Foundation for Women's Cancer (FWC) BRIDGES Accelerator Research Grants support BRIDGES scholars' gynecologic cancer research to speed interventional clinical trial launches or broaden their impact.
Funder: Foundation for Women's Cancer
Due Dates (Anticipated): October 2026 (LOI) | December 2026 (Full proposal)
Funding Amounts: Two one-year grants of up to $50,000 each
Summary: Supports BRIDGES scholars’ research to accelerate interventional clinical trial launch or expand trial impact.
Key Information: Applicants must be current or former SGO/GOG-F BRIDGES Scholars developing an interventional trial with BRIDGES faculty mentorship.
The Foundation for Women’s Cancer (FWC) offers BRIDGES Accelerator Research Grants within its gynecologic cancer research portfolio to amplify the impact of BRIDGES research protocols. The program supports work that accelerates the launch of interventional clinical trials or broadens their impact.
Supported activities include preclinical studies of agent activity, tissue-based endpoints, and toxicity or dose selection; pilot studies validating surveys or translating patient materials; and community outreach through advisory boards and patient advocates. Funding can also support correlative studies confirming on-target effects or identifying biomarkers for phase II/III trials, multisite expansion through BRIDGES scholar collaborations, and real-world data informing trial design and clinical relevance. Other initiatives that accelerate trial launch or expand trial impact are also welcome.